TheStreet.com RealMoney

A Ray of Hope From Amgen

By Jim Cramer

 About this article:
 Amgen's a reminder that not everything's one big macro trade. The issue that I think has most people stumbling around for answers in this market is the irrelevance of the underlying security vs. the actual overall market. Unless you are in a rare takeover, like a Tween Brands , you are really fighting the commoditization headwinds of stocks, which trade more off of Obama plans or oil futures, the first wildly negative and the second totally fixed, and I don't mean repaired. And then along comes Amgen to remind us that you buy stocks because they have innovations or superior earnings prospects or because they have new products that are game changers. Adam Feuerstein's Analysis Amgen Proves It Has The Superior Drug Of course, you are not going to move the needle with a new product from Procter & Gamble , or a new tissue from...

You have just read the beginning of a premium article from our RealMoney Service. To read the rest of this article and sign up for a FREE trial please click below.

ACCESS STORY & START A FREE 14-Day Trial
Or, call us at 1-866-321-TSCM (8726) Monday-Friday, 8 a.m.-6 p.m. ET.
Outside the U.S. and in Canada, call 1-212-321-5200.



Already a RealMoney subscriber? LOG IN.
Username: Page data is submitted securely.
Password:
Forgot your Password? Click here


100% Money-Back Guarantee
If you decide to subscribe and you're not completely satisfied with TheStreet.com RealMoney, just call us within the first 30 days of your subscription and we'll refund your full annual subscription price — guaranteed.




If you choose a 14-day free trial of RealMoney and you do NOT call to cancel within those 14 days, you will pay $129.95 — a $100 savings off the regular annual subscription price of $229.95. Unless you cancel before the end of that year, your subscription will automatically renew for another year at the then-current subscription price.

Offer applies only to new annual subscriptions, and is subject to change at any time. Void where prohibited.

If you choose a monthly subscription, you pay $34.95 per month. You will be notified if the current monthly rate of $34.95 changes at any time in the future.

TheStreet.com is a publisher. None of the contributors or their affiliates will provide you with personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. From time to time, any or all of the contributors or their affiliates may hold positions in securities mentioned and they may trade for their own accounts. In cases where the position is held at the time of publication, appropriate disclosure is made.

© TheStreet.com, Inc., 14 Wall Street, 15th Floor, New York, NY 10005.